Serum metabolic profile of postoperative acute kidney injury following infant cardiac surgery with cardiopulmonary bypass.
Jesse A Davidson, Benjamin S Frank, Tracy T Urban, Mark Twite, James Jaggers, Ludmila Khailova, Jelena Klawitter
Author Information
Jesse A Davidson: Department of Pediatrics, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA. jesse.davidson@childrenscolorado.org. ORCID
Benjamin S Frank: Department of Pediatrics, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA.
Tracy T Urban: Children's Hospital Colorado Research Institute, Aurora, CO, USA.
Mark Twite: Department of Anesthesiology, University of Colorado, Aurora, CO, USA.
James Jaggers: Department of Surgery, University of Colorado, Aurora, CO, USA.
Ludmila Khailova: Department of Pediatrics, Children's Hospital Colorado, University of Colorado, Aurora, CO, USA.
Jelena Klawitter: Department of Anesthesiology, University of Colorado, Aurora, CO, USA.
BACKGROUND: We sought to determine differences in the circulating metabolic profile of Infants with or without acute kidney injury (AKI) following cardiothoracic surgery with cardiopulmonary bypass (CPB). METHODS: We performed a secondary analysis of preoperative and 24-h postoperative serum samples from Infants ≤ 120 days old undergoing CPB. Metabolic profiling of the serum samples was performed by targeted analysis of 165 serum metabolites via tandem mass spectrometry. We then compared Infants who did or did not develop AKI in the first 72 h postoperatively to determine global differences in the preoperative and 24-h metabolic profiles in addition to specific differences in individual metabolites. RESULTS: A total of 57 Infants were included in the study. Six Infants (11%) developed KDIGO stage 2/3 AKI and 13 (23%) developed stage 1 AKI. The preoperative metabolic profile did not differentiate between Infants with or without AKI. Infants with severe AKI could be moderately distinguished from Infants without AKI by their 24-h metabolic profile, while Infants with stage 1 AKI segregated into two groups, overlapping with either the no AKI or severe AKI groups. Differences in these 24-h metabolic profiles were driven by 21 metabolites significant at an adjusted false discovery rate of < 0.05. Prominently altered pathways include purine, methionine, and kynurenine/nicotinamide metabolism. CONCLUSION: Moderate-to-severe AKI after infant cardiac surgery is associated with changes in the serum metabolome, including prominent changes to purine, methionine, and kynurenine/nicotinamide metabolism. A portion of Infants with mild AKI demonstrated similar metabolic changes, suggesting a potential role for metabolic analysis in the evaluation of lower stage injury.
